Prof. of Pediatrics, Université Paris Cité; Hemato-Immunology, Robert Debré Hospital APHP, Paris
Verified email at
Cited by
Cited by
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ...
New England Journal of Medicine 378 (5), 439-448, 2018
Childhood acute lymphoblastic leukemia: progress through collaboration
CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ...
Journal of Clinical Oncology 33 (27), 2938, 2015
Outcome of treatment in children with Philadelphia chromosome–positive acute lymphoblastic leukemia
M Aricò, MG Valsecchi, B Camitta, M Schrappe, J Chessells, A Baruchel, ...
New England Journal of Medicine 342 (14), 998-1006, 2000
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel, MF Auclerc, V Lhéritier, Y Perel, X Thomas, T Leblanc, ...
Journal of Clinical Oncology 21 (5), 774-780, 2003
L‐asparaginase treatment in acute lymphoblastic leukemia A focus on Erwinia asparaginase
R Pieters, SP Hunger, J Boos, C Rizzari, L Silverman, A Baruchel, ...
Cancer 117 (2), 238-249, 2011
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region
CH Pui, PS Gaynon, JM Boyett, JM Chessells, A Baruchel, W Kamps, ...
The Lancet 359 (9321), 1909-1915, 2002
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
N Boissel, H Leroy, B Brethon, N Philippe, S De Botton, A Auvrignon, ...
Leukemia 20 (6), 965-970, 2006
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008
M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, ...
Leukemia 24 (3), 521-535, 2010
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
J Soulier, E Clappier, JM Cayuela, A Regnault, M García-Peydró, ...
Blood 106 (1), 274-286, 2005
Outcomes after induction failure in childhood acute lymphoblastic leukemia
M Schrappe, SP Hunger, CH Pui, V Saha, PS Gaynon, A Baruchel, ...
New England Journal of Medicine 366 (15), 1371-1381, 2012
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey
MO Chandesris, I Melki, A Natividad, A Puel, C Fieschi, L Yun, ...
Medicine 91 (4), e1-e19, 2012
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
IHIM Hollink, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ...
Blood, The Journal of the American Society of Hematology 118 (13), 3645-3656, 2011
The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T …
E Clappier, W Cuccuini, A Kalota, A Crinquette, JM Cayuela, WA Dik, ...
Blood, The Journal of the American Society of Hematology 110 (4), 1251-1261, 2007
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
CH Pui, JM Chessells, B Camitta, A Baruchel, A Biondi, JM Boyett, ...
Leukemia 17 (4), 700-706, 2003
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
O Bluteau, M Sebert, T Leblanc, R Peffault de Latour, S Quentin, E Lainey, ...
Blood, The Journal of the American Society of Hematology 131 (7), 717-732, 2018
Clinical outcome of children with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia treated between 1995 and 2005
M Aricò, M Schrappe, SP Hunger, WL Carroll, V Conter, S Galimberti, ...
Journal of clinical oncology 28 (31), 4755, 2010
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ...
The Lancet 396 (10266), 1885-1894, 2020
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
MM Coudé, T Braun, J Berrou, M Dupont, S Bertrand, A Masse, E Raffoux, ...
Oncotarget 6 (19), 17698, 2015
New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children
N Aladjidi, G Leverger, T Leblanc, MQ Picat, G Michel, Y Bertrand, ...
haematologica 96 (5), 655, 2011
Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
U Fischer, M Forster, A Rinaldi, T Risch, S Sungalee, HJ Warnatz, ...
Nature genetics 47 (9), 1020-1029, 2015
The system can't perform the operation now. Try again later.
Articles 1–20